MYR's Seed VC Round

MYR raised a round of funding on May 20, 2011. Investors include High-Tech Grunderfonds.

MYR is a German biotechnology company developing Myrcludex B, a drug for the treatment of chronic hepatitis B and delta virus infections. The drug inhibits the recently identified HBV receptor on the …

Articles about MYR's Seed VC Round: